In conclusion, a gene that was highly expressed in brain tissues, peripheral blood, and cerebrospinal fluid of AD patients, PTAFR was found to be a potential candidate biomarker for AD diagnosis. This evidence concerns the gene PTAFR and Alzheimer disease.